Xiangjun Qi

7PUBLICATIONS
17CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Pacific Peoples diet and nutritionMolecular targetsChemotherapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jul 15, 2026
Clinical Study on the Prevention of High-Risk Pulmonary Nodule Progression With Yifei Sanjie Pill: Protocol for a Multicenter Randomized Controlled Trial.

|Jan 08, 2026
Chlorogenic Acid Regulates Macrophage Polarization in LUAD by Inhibiting Taurodeoxycholic Acid Metabolism to Block the TGR5/STAT3 Signaling Pathway.

Xiwu Rao, Zhiqiang Chen, Xiangjun Qi

|Dec 18, 2025
Association Between Exposure to Phenols and Parabens and Allergy-Related Outcomes.

Caishan Fang, Xiangjun Qi, Qinwei Fu

|Jan 30, 2023
Yifei Sanjie Formula or Placebo With Anlotinib as Second-Line or Above Treatment for Metastatic Non-Small-Cell Lung Cancer: Study Protocol for a Double-Blind, Placebo-Controlled Randomized Pilot Study.

Wenmin Chen, Jietao Lin, Ting Yang

|Nov 28, 2022
Cuproptosis-Related Signature Predicts the Prognosis, Tumor Microenvironment, and Drug Sensitivity of Hepatocellular Carcinoma.

Xiangjun Qi, Jiayun Guo, Guoming Chen

|Aug 23, 2021
Construction of a Novel Lung Adenocarcinoma Immune-Related lncRNA Pair Signature.

Xiangjun Qi, Guoming Chen, Zhuangzhong Chen

Pageof 2

Frequent Collaborators

2 joint publications

Lizhu Lin

2 joint publications

Caishan Fang

2 joint publications

Jietao Lin

1 joint publications

Jing Li